&Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95M | Buy |
23,566
+5,323
| +29% | +$441K | 0.02% | 678 |
|
2025
Q1 | $1.54M | Sell |
18,243
-104
| -0.6% | -$8.78K | 0.02% | 641 |
|
2024
Q4 | $1.69M | Buy |
18,347
+11,678
| +175% | +$1.08M | 0.02% | 567 |
|
2024
Q3 | $659K | Buy |
6,669
+730
| +12% | +$72.1K | 0.01% | 739 |
|
2024
Q2 | $551K | Buy |
5,939
+460
| +8% | +$42.6K | 0.02% | 506 |
|
2024
Q1 | $520K | Hold |
5,479
| – | – | 0.07% | 258 |
|
2023
Q4 | $489K | Buy |
5,479
+6
| +0.1% | +$536 | 0.12% | 158 |
|
2023
Q3 | $400K | Sell |
5,473
-1,130
| -17% | -$82.5K | 0.19% | 99 |
|
2023
Q2 | $549K | Hold |
6,603
| – | – | 0.25% | 78 |
|
2023
Q1 | $503K | Hold |
6,603
| – | – | 0.24% | 85 |
|
2022
Q4 | $548K | Sell |
6,603
-100
| -1% | -$8.3K | 0.27% | 75 |
|
2022
Q3 | $532K | Sell |
6,703
-145
| -2% | -$11.5K | 0.31% | 75 |
|
2022
Q2 | $509K | Buy |
6,848
+473
| +7% | +$35.2K | 0.29% | 79 |
|
2022
Q1 | $573K | Sell |
6,375
-50
| -0.8% | -$4.49K | 0.32% | 74 |
|
2021
Q4 | $719K | Buy |
6,425
+500
| +8% | +$56K | 0.43% | 56 |
|
2021
Q3 | $745K | Sell |
5,925
-110
| -2% | -$13.8K | 0.47% | 53 |
|
2021
Q2 | $817K | Buy |
6,035
+220
| +4% | +$29.8K | 0.53% | 42 |
|
2021
Q1 | $789K | Hold |
5,815
| – | – | 0.57% | 44 |
|
2020
Q4 | $819K | Sell |
5,815
-225
| -4% | -$31.7K | 0.69% | 41 |
|
2020
Q3 | $673K | Hold |
6,040
| – | – | 0.68% | 43 |
|
2020
Q2 | $676K | Sell |
6,040
-200
| -3% | -$22.4K | 0.82% | 35 |
|
2020
Q1 | $483K | Hold |
6,240
| – | – | 0.75% | 40 |
|
2019
Q4 | $593K | Hold |
6,240
| – | – | 0.71% | 47 |
|
2019
Q3 | $476K | Sell |
6,240
-375
| -6% | -$28.6K | 0.62% | 59 |
|
2019
Q2 | $580K | Hold |
6,615
| – | – | 0.8% | 41 |
|
2019
Q1 | $599K | Buy |
6,615
+60
| +0.9% | +$5.43K | 0.86% | 35 |
|
2018
Q4 | $461K | Buy |
+6,555
| New | +$461K | 0.77% | 37 |
|